Pharma Research
Terumo and UMCU to develop solutions in Interventional Oncology
Terumo Europe and University Medical Center Utrecht (UMC Utrecht) announced today that they signed a Memorandum of Understanding (MoU) to recognize the lon...
July 21, 2021 | News
Thermo Fisher Scientific Expands Hematology Oncology NGS Portfolio
Thermo Fisher Scientific today announced a new suite of Ion Torrent Oncomine immune repertoire assays designed to detect potentially malignant cl...
July 20, 2021 | News
SP’s fill-finish system chosen by NIBRT to deliver advanced training in biopharmaceutical production
SP Scientific Products (SP) announces a collaboration with the National Institute for Bioprocessing Research and Training (NIBRT) in Dublin, Irel...
July 20, 2021 | News
Curia to Acquire US-Based LakePharma
Adds integrated biologics development platform from discovery through GMP manufacturing Curia, formerly AMRI, a leading contract research, development and...
July 19, 2021 | News
USP acquires Pharmatech Associates
United States Pharmacopeia (USP), an independent, scientific nonprofit organization, is pleased to announce the acquisition of Pharmatech Associates, Inc. ...
July 13, 2021 | News
Collaboration Between Abbvie, Biogen and Pfizer
Access to the world’s largest browsable resource linking rare protein-coding genetic variants to human health and disease was launched through a gene...
July 12, 2021 | News
Hummingbird Bioscience and MD Anderson To Advance Innovative Immunotherapies
Hummingbird Bioscience, an innovative clinical-stage biotech company focused on developing precision therapies against hard-to-drug targets to produce majo...
July 12, 2021 | News
MiRXES Secures US$77 Million To Accelerate Multi-Cancer Early Detection
MiRXES Pte Ltd, a biotechnology company focused on improving and saving lives with RNA-powered disease early detection tests, announced today it has ...
July 12, 2021 | News
I-Mab Expands Next Generation Novel Oncology Therapeutics
I-Mab (the "Company") (Nasdaq: IMAB), a clinical stage biopharmaceutical company committed to the discovery, development and commercialization of novel bio...
July 10, 2021 | News
Elekta optimizes treatment times for cancer patients
For the last several years, Elekta (EKTA-B.ST) has invested substantially in digitized service solutions to keep critical treatment machines up and running...
July 07, 2021 | News
Y-Biologics & Pierre Fabre enter into an agreement in the field of immuno-oncology
These antibodies have been functionally validated by the Pierre Fabre R&D teams for their specific properties on a pivotal immuno-oncology target actin...
July 06, 2021 | News
Roche to drive therapies to treat breast and lung cancer
According to Globocan, in 2020 the global burden of cancer increased to 19.3 million new cases and 10 million deaths[1]. Worldwide, the most common type of...
July 06, 2021 | News
SINOMED announces a clinical collaboration with the National University of Ireland Galway
The PIONEER IV trial is a prospective, random trial that will take place in 30 hospitals across Europe, enrolling 2,540 patients and involve patient...
July 05, 2021 | News
BioMed X & Merck KGaA, Darmstad Launch New Research Program in Oncology
BioMed X Institute expands its collaboration with Merck KGaA, Darmstadt, Germany to a total of eight research programs. Call for application of ...
July 05, 2021 | News
Most Read
- Bridging the Vision Gap: Roche’s Ahmed Elhusseiny on Eye Health Priorities in Asia Pacific
- How Merck’s India-Based Navi Mumbai Centre is Reimagining Formulation Science for the Global Generics Market
- Advancing Cell & Gene Therapy in APJ: How Thermo Fisher Enables Breakthrough Innovation
- AstraZeneca’s Vision for Chronic Kidney Disease: Sylvia Varela on Transforming CKD Care in Asia
- ACG Leads the Charge in Vegan Capsules: Innovation, Certification, and the Future of Sustainable Pharma
- ORA’s Hybrid Model Reshapes Obesity Care: Dr. Ben Ng on Bridging Telehealth and In-Person Treatment
- Heather Hargett on How Merck’s HUB Organoids Acquisition is Reshaping 3D Cell Culture and Drug Development
- Health2Sync's Vision for Diabetes Care: Transforming Outcomes Through Technology and Partnerships
Bio Jobs
- Ravindra Rao Joins GOBI Technologies as Director of Life Sciences – APAC
- Amgen Announces $900 Million Expansion of Ohio Biomanufacturing Facility, Boosting Investment to Over $1.4 Billion
- Thermo Fisher Scientific Appoints Former CVS Health CEO Karen S. Lynch to Board of Directors
- Merck KGaA Reshapes Leadership for the Future with Key Executive Moves
- Aarian Health Appoints Thomas Keller as Business Director to Drive Innovation and Growth
- Top Management Shakeups of 2024: Redefining Pharma, Biopharma, and Biotech Leadership
News
Editor Picks
